Results 231 to 240 of about 1,107,019 (331)
Hepatotoxic Effect of Bile Acids in Inflammatory Bowel Disease
M. J. Dew +3 more
openalex +1 more source
Failure to record variables of growth and development in children with inflammatory bowel disease. [PDF]
J R Barton, A Ferguson
openalex +1 more source
Native thioredoxin‐1 (TRX) stimulates proliferation and rescues stem cells and cancer cells from multiple stressors by suppressing p53 and inhibiting ferroptosis via GPX4/SLC7A11 upregulation mediated by enhanced KLF4 expression and p53 promoter binding.
Jian Wu +18 more
wiley +1 more source
Transperineal ultrasound: Role in inflammatory bowel disease management. [PDF]
Pal P +5 more
europepmc +1 more source
In intestinal stem cells (ISCs), Snord15b associates with Ilf2 to recruit splicing factors for alternative splicing of Btrc mRNA, leading to the generation of short Btrc. This short Btrc fails to form a functional E3 ubiquitin ligase complex for β‐catenin ubiquitination and degradation.
Yuwei Xu +13 more
wiley +1 more source
Hemorheology in Inflammatory Bowel Disease: A Case-Control Study. [PDF]
Szakács Z +8 more
europepmc +1 more source
Monoclonal B Lymphocytes in the Peripheral Blood of Patients with Inflammatory Bowel Disease
Carla H. Ginsburg +2 more
openalex +1 more source
Nanographene oxide (NGO) attenuates graft‐versus‐host disease (GVHD) severity by inhibiting STAT1‐mediated M1 macrophage polarization and suppressing T‐cell activation. NGO‐primed macrophages (NGO‐Mac) further enhance regulatory T‐cell induction via IL‐10. Both NGO and NGO‐Mac therapies mitigate inflammation and immune pathology, offering cell‐free and
Aaron Yu +18 more
wiley +1 more source
The Place of Appendicectomy in Inflammatory Bowel Disease-A Review. [PDF]
Naidu K +4 more
europepmc +1 more source

